243 related articles for article (PubMed ID: 24895412)
1. TIMP-1 via TWIST1 induces EMT phenotypes in human breast epithelial cells.
D'Angelo RC; Liu XW; Najy AJ; Jung YS; Won J; Chai KX; Fridman R; Kim HR
Mol Cancer Res; 2014 Sep; 12(9):1324-33. PubMed ID: 24895412
[TBL] [Abstract][Full Text] [Related]
2. Temporal and spatial cooperation of Snail1 and Twist1 during epithelial-mesenchymal transition predicts for human breast cancer recurrence.
Tran DD; Corsa CA; Biswas H; Aft RL; Longmore GD
Mol Cancer Res; 2011 Dec; 9(12):1644-57. PubMed ID: 22006115
[TBL] [Abstract][Full Text] [Related]
3. TRIM29 suppresses TWIST1 and invasive breast cancer behavior.
Ai L; Kim WJ; Alpay M; Tang M; Pardo CE; Hatakeyama S; May WS; Kladde MP; Heldermon CD; Siegel EM; Brown KD
Cancer Res; 2014 Sep; 74(17):4875-87. PubMed ID: 24950909
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines.
Dong P; Kaneuchi M; Watari H; Sudo S; Sakuragi N
Mol Carcinog; 2014 May; 53(5):349-59. PubMed ID: 24002805
[TBL] [Abstract][Full Text] [Related]
5. TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation.
Drasin DJ; Guarnieri AL; Neelakantan D; Kim J; Cabrera JH; Wang CA; Zaberezhnyy V; Gasparini P; Cascione L; Huebner K; Tan AC; Ford HL
Cancer Res; 2015 May; 75(9):1908-21. PubMed ID: 25716682
[TBL] [Abstract][Full Text] [Related]
6. Over-Expressed Twist Associates with Markers of Epithelial Mesenchymal Transition and Predicts Poor Prognosis in Breast Cancers via ERK and Akt Activation.
Zhang YQ; Wei XL; Liang YK; Chen WL; Zhang F; Bai JW; Qiu SQ; Du CW; Huang WH; Zhang GJ
PLoS One; 2015; 10(8):e0135851. PubMed ID: 26295469
[TBL] [Abstract][Full Text] [Related]
7. TIMP-1 induces an EMT-like phenotypic conversion in MDCK cells independent of its MMP-inhibitory domain.
Jung YS; Liu XW; Chirco R; Warner RB; Fridman R; Kim HR
PLoS One; 2012; 7(6):e38773. PubMed ID: 22701711
[TBL] [Abstract][Full Text] [Related]
8. Twist1 and AP-1 cooperatively upregulate integrin α5 expression to induce invasion and the epithelial-mesenchymal transition.
Nam EH; Lee Y; Moon B; Lee JW; Kim S
Carcinogenesis; 2015 Mar; 36(3):327-37. PubMed ID: 25600770
[TBL] [Abstract][Full Text] [Related]
9. Sox5 induces epithelial to mesenchymal transition by transactivation of Twist1.
Pei XH; Lv XQ; Li HX
Biochem Biophys Res Commun; 2014 Mar; 446(1):322-7. PubMed ID: 24607904
[TBL] [Abstract][Full Text] [Related]
10. Establishment of twist-1 and TGFBR2 as direct targets of microRNA-20a in mesenchymal to epithelial transition of breast cancer cell-line MDA-MB-231.
De S; Das S; Mukherjee S; Das S; Sengupta Bandyopadhyay S
Exp Cell Res; 2017 Dec; 361(1):85-92. PubMed ID: 28987542
[TBL] [Abstract][Full Text] [Related]
11. Promotion of hepatocellular carcinoma metastasis through matrix metalloproteinase activation by epithelial-mesenchymal transition regulator Twist1.
Zhao XL; Sun T; Che N; Sun D; Zhao N; Dong XY; Gu Q; Yao Z; Sun BC
J Cell Mol Med; 2011 Mar; 15(3):691-700. PubMed ID: 20219012
[TBL] [Abstract][Full Text] [Related]
12. Quercetin restrains TGF-β1-induced epithelial-mesenchymal transition by inhibiting Twist1 and regulating E-cadherin expression.
Feng J; Song D; Jiang S; Yang X; Ding T; Zhang H; Luo J; Liao J; Yin Q
Biochem Biophys Res Commun; 2018 Mar; 498(1):132-138. PubMed ID: 29425820
[TBL] [Abstract][Full Text] [Related]
13. Twist1 regulates the epithelial-mesenchymal transition via the NF-κB pathway in papillary thyroid carcinoma.
Lv N; Shan Z; Gao Y; Guan H; Fan C; Wang H; Teng W
Endocrine; 2016 Mar; 51(3):469-77. PubMed ID: 26289126
[TBL] [Abstract][Full Text] [Related]
14. CRH suppressed TGFβ1-induced Epithelial-Mesenchymal Transition via induction of E-cadherin in breast cancer cells.
Jin L; Chen J; Li L; Li C; Chen C; Li S
Cell Signal; 2014 Apr; 26(4):757-65. PubMed ID: 24412750
[TBL] [Abstract][Full Text] [Related]
15. Tripartite motif containing 28 (TRIM28) promotes breast cancer metastasis by stabilizing TWIST1 protein.
Wei C; Cheng J; Zhou B; Zhu L; Khan MA; He T; Zhou S; He J; Lu X; Chen H; Zhang D; Zhao Y; Fu J
Sci Rep; 2016 Jul; 6():29822. PubMed ID: 27412325
[TBL] [Abstract][Full Text] [Related]
16. Runt-related transcription factor 3 reverses epithelial-mesenchymal transition in hepatocellular carcinoma.
Tanaka S; Shiraha H; Nakanishi Y; Nishina S; Matsubara M; Horiguchi S; Takaoka N; Iwamuro M; Kataoka J; Kuwaki K; Hagihara H; Toshimori J; Ohnishi H; Takaki A; Nakamura S; Nouso K; Yagi T; Yamamoto K
Int J Cancer; 2012 Dec; 131(11):2537-46. PubMed ID: 22488108
[TBL] [Abstract][Full Text] [Related]
17. Identification of CD63 as a tissue inhibitor of metalloproteinase-1 interacting cell surface protein.
Jung KK; Liu XW; Chirco R; Fridman R; Kim HR
EMBO J; 2006 Sep; 25(17):3934-42. PubMed ID: 16917503
[TBL] [Abstract][Full Text] [Related]
18. Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition.
Khan MA; Tania M; Wei C; Mei Z; Fu S; Cheng J; Xu J; Fu J
Oncotarget; 2015 Aug; 6(23):19580-91. PubMed ID: 26023736
[TBL] [Abstract][Full Text] [Related]
19. MiR-137 regulates epithelial-mesenchymal transition in gastrointestinal stromal tumor.
Liu S; Cui J; Liao G; Zhang Y; Ye K; Lu T; Qi J; Wan G
Tumour Biol; 2014 Sep; 35(9):9131-8. PubMed ID: 25027394
[TBL] [Abstract][Full Text] [Related]
20. Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer.
Talati PG; Gu L; Ellsworth EM; Girondo MA; Trerotola M; Hoang DT; Leiby B; Dagvadorj A; McCue PA; Lallas CD; Trabulsi EJ; Gomella L; Aplin AE; Languino L; Fatatis A; Rui H; Nevalainen MT
Am J Pathol; 2015 Sep; 185(9):2505-22. PubMed ID: 26362718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]